Skip to main content
48°
Light Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Intellia Thera CS
(NQ:
NTLA
)
24.86
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
200
Open
24.86
Bid (Size)
24.50 (1)
Ask (Size)
28.00 (3)
Prev. Close
24.86
Today's Range
24.86 - 24.86
52wk Range
19.37 - 47.48
Shares Outstanding
88,140,978
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
NTLA Stock Earnings: Intellia Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
NTLA stock results show that Intellia Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Just Say No to Drugs: 3 Pharma Stocks to Avoid
May 08, 2024
Discover which pharma stocks to avoid in 2023 as we delve into market trends, financial struggles, and the impact on investor portfolios.
Via
InvestorPlace
Performance
YTD
-19.34%
-19.34%
1 Month
-4.68%
-4.68%
3 Month
-9.50%
-9.50%
6 Month
-0.40%
-0.40%
1 Year
-44.99%
-44.99%
More News
Read More
Why Intellia Therapeutics, Inc. Outpaced the Stock Market
May 05, 2024
Via
Talk Markets
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar
May 03, 2024
Via
InvestorPlace
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
May 02, 2024
Via
InvestorPlace
2 Stocks Down 30% to Buy Right Now
April 14, 2024
Via
The Motley Fool
Is Intellia Therapeutics Stock a Buy Now?
March 09, 2024
Via
The Motley Fool
A Preview Of Intellia Therapeutics's Earnings
February 21, 2024
Via
Benzinga
Cathie Wood Goes Bargain Hunting. 2 Stocks She Bought This Week.
April 12, 2024
Via
The Motley Fool
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
April 09, 2024
Via
The Motley Fool
Kuehn Law Encourages Investors of Intellia Therapeutics, Inc. to Contact Law Firm
April 02, 2024
Via
News Direct
ARKK’s Tech Bets: Over 500k Roblox Shares Purchased, 1.24M Robinhood Shares Sold
March 29, 2024
Via
Talk Markets
Topics
ETFs
Better Cathie Wood Stock: Moderna vs. Intellia
March 28, 2024
Via
The Motley Fool
Hot Stocks: The 3 Best Opportunities for Investing in Biotech
March 21, 2024
Via
InvestorPlace
3 Stocks That Could Be the Next Big Thing in Gene Editing
March 21, 2024
Via
InvestorPlace
Intellia Therapeutics Stock Has 119% Upside, According to 1 Wall Street Analyst
March 06, 2024
Via
The Motley Fool
A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now
February 29, 2024
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
February 27, 2024
Via
The Motley Fool
Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed
February 26, 2024
Via
Benzinga
Is CRISPR Therapeutics the NVIDIA of gene editing?
February 26, 2024
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Cathie Wood Is Betting on This Top Technology: 2 Stocks She Just Bought
February 20, 2024
Via
The Motley Fool
3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential
February 19, 2024
Via
InvestorPlace
Analysts Say Intellia Therapeutics Stock Could Rise 157% This Year, but Will It Happen?
February 17, 2024
Via
The Motley Fool
Earnings Scheduled For February 22, 2024
February 22, 2024
Via
Benzinga
Intellia Therapeutics and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis
February 15, 2024
From
ReCode Therapeutics
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.